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During their extended evolution genes coding for aminoacyl-tRNA synthetases (ARS) have experi-
enced numerous instances of duplication, insertion and deletion of domains. The ARS-related pro-
teins that have resulted from these genetic events are generally known as aminoacyl-tRNA
synthetase-like proteins (ARS-like). This heterogeneous group of polypeptides carries out an equally
varied number of functions that need not be related to gene translation. Several of these proteins
remain uncharacterized. At least 16 different ARS-like proteins have been identiﬁed to date, but
their functions remain incompletely understood. Here we review the individual phylogenetic distri-
bution of these proteins in bacteria, and apply a new genomics method to determine their potential
implication in pathogenicity.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction complex biological phenotypes can be a powerful tool for the iden-Aminoacyl-tRNA synthetases represent an extraordinary exam-
ple of functional and structural conservation [1]. Across all living
species most of these enzymes display an almost identical struc-
ture, providing one of the few cases where phylogenetic and struc-
tural analyses can be expected to yield information about the ﬁrst
evolutionary steps of cellular life on earth [2–4]. As would be ex-
pected from a large group of enzymes, with complicated modular
structures and extremely long evolutionary lives, a large group of
related proteins has formed as a result of total or partial duplica-
tions of ARS genes [5,6]. In addition, some ARS-like proteins may
exist that are coded by ancestral genes that were lately fused to
a pre-existing ARS. Differentiating between these two possibilities
can be difﬁcult.
Functionally speaking ARS-like proteins are not a homogeneous
class. However, a global analysis of their distribution is interesting
because it provides information on the evolutionary history of ARS,
and it might help to identify tendencies in the functional roles that
ARS-related domains adopt when they diverge from their ancestral
enzymes. Moreover, the species distribution of each ARS-like pro-
tein is likely to provide information on its biological role. More spe-
ciﬁcally, the search for correlations between gene distribution andchemical Societies. Published by E
search in Biomedicine (IRB),
as de Pouplana).tiﬁcation of biological function.
Herewe combine the analysis of the phylogenetic distribution of
bacterial ARS-like proteinswith a simple and rapid algorithm for the
identiﬁcation of proteins that are over-represented in human path-
ogenic organisms. First, we have applied our method to re-examine
the different ARS-like proteins found in bacteria, clustering them
according to a sequence-similarity proﬁle. Secondly, we have ana-
lyzedwhether each of the 11 bacterial ARS-like proteins that we ob-
tain is functionally linked to bacterial virulence (Fig. 1). Ourmethod
positively identiﬁesAsnAasover-represented inpathogenic species.
AsnAhas alreadybeendescribedas important inbacterial pathogens
of plants and animals [7,8]. We suggest that its importance in infec-
tion may be extended to human microbial infections.
2. Methods
2.1. Protein proﬁle generation and determination of phylogenetic
distributions
We selected 16 well-documented ARS-like proteins for our
study (Table 1). For each of them, a multiple alignment was built
with ClustalW [29] using the Gonnet protein matrix, followed by
a Hidden Markov proﬁle building using the HMMER package
[30]. Each protein proﬁle was used as query to ﬁnd all existing
homologues in the Uniprot database (www.uniprot.org). In order
to apply a consistent criterion to the determination of each
protein’s distribution we applied a cutoff value to the search forlsevier B.V. All rights reserved.
Fig. 1. Schematic representation of the over-representation analysis performed in this work.
Table 1
List of the 16 ARS-like proteins considered in this study.
Synthetase-like aaRS paralog Reference
Ybak ProRS [9,10]
HisZ HisRS [11,12]
AlaX AlaRS [5,13]
PrdX (ProX) ProRS [13,14]
GluX (YadB) GluRS [15]
CTP Class I ARS [16]
ATPS Class I ARS [16]
EMAP-II MetRS, TyrRS [17–19]
Arc1p MetRS, TyrRS [20]
Trbp111 MetRS, TyrRS [21]
BirA SerRS [22,23]
AsnA AspRS, AsnRS [24,25]
ThrRS-ed ThrRS [26]
Gcn2 HisRS [11]
Pol gamma B GlyRS [27]
PoxA/GenX LysRS [28]
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identiﬁed clusters of proteins that were considered as
evolutionarily related and treated as a single family. Those families
present in bacteria were selected for further analysis. The distribu-
tion found for each bacterial ARS-like family was graphically dis-
played through the quantiﬁcation of all its homologous sequences
in themain bacterial phyla and the representation of these frequen-
cies on a model phylogenetic tree of bacteria [31] (Fig. 2).
To correct for the fact that not all bacterial phyla are equally rep-
resented among the Uniprot database, a standardization of the val-
ues of the ARS-like proteins was done in order to obtain ﬁnal values
comparable among the different bacterial phyla. The relative abun-
dance of each protein in a phylum was computed by dividing thenumber of protein hits found in that phylum by the total number
of proteins found for the phylum in the Uniprot database:
Relative abundance ¼ No: “X” in phylum
No: proteins of phylum in Uniprot
ð1Þ
Since a protein of a given species may be represented more than
once in the Uniprot database – e.g. same protein from different
strains –, only semi-quantitative values can be obtained from this
analysis. Nevertheless, the calculation is accurate enough to pro-
vide an estimation of the distribution of each ARS-like protein
among bacterial phyla.2.2. Correlation analysis of protein distributions and pathogenicity
2.2.1. Database preparation and construction of the set of human
pathogens
In order to identify proteins over-represented in pathogenic
species the curated set of complete proteomes from the Integr8
database (2069 complete proteomes) was used (www.ebi.ac.uk/in-
tegr8). This collection was further modiﬁed to obtain our ﬁnal pro-
teome dataset (viral proteomes were removed and only one
proteome per species was used) of 910 complete proteomes.
In over-representation studies a carefully curated dataset is
essential to avoid artiﬁcial over-representation of data (e.g. frag-
ments of the proteins, point mutations, more that one strain per
species) that leads to non-reliable values of enrichment. From
the ﬁnal dataset of 910 complete proteomes, 168 were identiﬁed
as belonging to human pathogens. This was done with the help
of different curated databases: HAMAP database (http://www.
expasy.ch/sprot/hamap/), pathogenic bacteria database (bac.hs.
med.kyoto-u.ac.jp), national microbiology pathogen data resource
(www.nmpdr.org), pathogenic fungi database (www.pfdb.net),
Fig. 2. Phylogenetic distribution and relative abundance of the 11 bacterial ARS-like proteins considered in this work. Each tree is labeled according to the protein whose
distribution is being analyzed. The tree labeled UNIPROT shows the number of proteins per phylum that are included in the database used. The relative abundance (r.a.) of
each protein in each phylum is represented by a colored circle at the end of the phylum’s branch: blue (r.a.P 25), salmon (r.a.P 10) and yellow (0 > r.a. > 10). Only bacterial
relative abundances are shown.
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Table 2
Overrepresentation values for the different ARS-like proteins, including the negative
and positive controls used in this study.
ER-proteins ER-species
Negative controls
Tubulin 1.1 1.55
Enolase 1.01 0.96
Alanyl-tRNA synthetase 1.14 1.02
Lactate deshydrogenase 0.89 0.86
Pyruvate deshydrogenase 0.93 0.92
Positive controls
Lipoteichoic acid synthase 1.24 1.17
Adhesin yadA 6.17 5.42
Haemolysin 2.06 1.81
Glutamyl transpeptidase 0.95 0.91
CapC 1.68 1.55
Fimbrial subunit precursor 2.26 2.71
LPS transferase 2.92 2.56
SycE secretion chaperone 3.08 2.71
Heme exporter protein 1.32 1.17
Fimbrial chaperone 2.46 1.87
Cholera enterotoxin 6.17 5.42
Streptococcal exotoxin 6.17 5.42
Coagulase 5.11 4.42
HifA – pilin 3.08 2.71
ARS-like proteins
AlaX 0.5 0.51
ThrX 1.11 1
AsnA 2.53 1.79
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tal (www.pathogenportal.org). The ﬁnal list of human pathogens
includes 146 bacteria, 11 fungi and 12 protozoa.
2.2.2. Construction of a control dataset
Both positive and negative controls were included in the study
for external validation of the method. Negative controls used are
proteins not expected to be over-represented in human pathogens
(tubulin, enolase, alanyl-tRNA synthetase, lactate dehydrogenase,
and pyruvate dehydrogenase). Positive controls were built with
proteins known to be linked to pathogenicity – e.g. virulence fac-
tors – (haemolysin, gamma-glutamyl transpeptidase, CapC, ﬁm2
ﬁmbrial subunit precursor, lipopolysaccharide transferase, sycE
secretion chaperone, heme exporter protein CcmC, long polar ﬁmb-
rial chaperone, adhesin, cholera enterotoxin, streptococcal exo-
toxin I and lipoteichoic acid synthase).
2.2.3. Calculation of over-representation indices
Protein proﬁles were built for both controls and test cases (ARS-
like proteins) following the same procedure explained above. Each
protein proﬁle was compared to our curated set of Integr8 proteo-
mes, to obtain the complete list of homologues for each of the pro-
teins among the 910 proteomes. We considered a protein as
pathogenicity-related if it was found over-represented in the set
of human pathogens compared to what is expected by chance.
Over-representation was measured using two different indices:
enrichment rate of the number of proteins (ER-proteins) and
enrichment rate of the number of species (ER-species), which are
computed as follows:
ER-species ¼ Pathogenic species with “X”=Species with “X”
Pathogenic species=Species in database
ð2Þ
ER-proteins ¼ No: “X” in path: spp=No: “X” in database
Proteins in path: spp=Proteins in database
ð3Þ
where ‘‘X” is the queried protein of interest.
Although both ratios quantify the over-representation of a given
protein among pathogen species they may produce different
enrichment ratios because a species can have one or more homo-
logues of the queried protein. Thus, enrichment must be quantiﬁed
both in terms of number of proteins and number of species.
Signiﬁcance testing on protein distribution results was per-
formed using a one-tailed test, and threshold values were com-
puted both for 1% and 0.1% false positive rates (FP) [32,33]. In
one-tailed tests, we can compute the threshold or cutoff value
depending on the false positive rates (FP) that we accept:
Threshold ð5% FPÞ ¼ X  1:64r_ ð4Þ
Threshold ð1% FPÞ ¼ X  2:32r_ ð5Þ
Threshold ð0:1% FPÞ ¼ X  3:09r_ ð6Þ
where X is the population mean and r
_
is the estimator of the stan-
dard deviation of the population. By plotting ER-species as a func-
tion of ER-proteins, control proteins that are not linked to
pathogenicity should be clustered around the (1, 1) coordinates. A
protein that is not over-represented is expected to fall into the nor-
mal distribution of the negative controls, with cutoff values that de-
pend on the rate of false positives that we accept.ATPS 0.76 0.69
BirA 0.97 0.87
CTP 1 0.91
GluX 1.21 1.43
HisZ 0.44 0.4
PoxA 1.29 0.97
PrdX (ProX) 0.86 0.77
Ybak 1.2 1.06
EMAP-II 1.13 0.983. Results
3.1. Distribution of bacterial ARS-like proteins
Analysis of the phylogenetic distributions among the different
bacterial phyla was performed for the complete set of ARS-like pro-teins (Fig. 2). From the 16 ARS-like proteins initially analyzed (Ta-
ble 1) Arc1p, Gcn2, ThrRS-ed, Polcb and AlaX2 were excluded
because their distribution was found to be limited to eukarya
(Gcn2 and Arc1p), archaea (ThrRS-ed), or eukarya and archaea
(AlaX2, Polcb). Emap-II and Trpb111 sequences were merged into
one unique class because 90% of the sequences identiﬁed as
Trbp111 are also present in the Emap-II proﬁle. The distributions
of the resulting 11 ARS-like proteins present in bacterial phyla
are shown in Fig. 2. Minority phyla have not been represented in
order to simplify the presentation of the results.
3.2. Identiﬁcation of pathogenicity-related ARS-like proteins
We have constructed a simple and fast algorithm to determine
whether a given protein is signiﬁcantly over-represented in patho-
genic organisms, and we have applied the method to bacterial ARS-
like proteins. We consider a protein as pathogenicity-related if it is
over-represented in a set of proteomes from human pathogens
compared to what it should be expected by chance.
We computed the enrichment values (ER-proteins and ER-spe-
cies, see Section 2), both for the set of controls and for the ARS-like
proteins (Table 2). By plotting the enrichment rates (Fig. 3), we can
clearly distinguish two differently distributed populations, corre-
sponding to the negative and positive controls. The negative con-
trol distribution is centered around ER-proteins = 1 and ER-
species = 1, whereas the positive control distribution (pathogenic-
ity-related) has a higher variance and goes from non-enrichment
values to high enrichment values. ARS-like proteins are mainly dis-
tributed among the negative control distribution, with the excep-
tion of AsnA, which clusters with pathogenicity-related proteins.
Fig. 3. Distribution of over-representation values for all ARS-like proteins (yellow boxes), and positive or negative controls for pathogenicity (red squares and blue diamonds,
respectively). The position of AsnA is marked by an arrow and labeled accordingly.
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performed using a one-tailed test as described above. Since the
ER-proteins mean for the negative controls is 1.014 ± 0.107, the
thresholds corresponding for 5% FP, 1% FP and 0.1% FP are 1.19,
1.26 and 1.34, respectively. Taking this into account, AsnA is not
a member of the negative control distribution with a P-value that
approaches zero even at 0.1% FP. Thus, our results suggest that
AsnA might be correlated with pathogenicity. GluX slightly devi-
ates from the negative control set, however ER-proteins and -spe-
cies values for GluX are below its respective cutoffs for a 1% false
positive rate. Thus we can conclude that this deviation is not statis-
tically signiﬁcant and that GluX is not over-represented in human
pathogens.
4. Discussion
The evolutionary relationships between ARS and ARS-like pro-
teins have been analyzed previously through the use of phyloge-
netic methods [3,34,35]. This approach represents the best
available strategy for the identiﬁcation of cladistic relationships,
but it is easily confounded by the extremely long evolutionary
times experienced by aminoacyl-tRNA synthetases and their re-
lated proteins. Irrespectively of clade relationships, the species dis-
tribution of genes represents important information that can be
linked to function and, indirectly, to evolutionary origin. Here we
have analyzed the distribution of an ARS-like proteins families in
bacteria and built a simple algorithm to analyze correlations be-
tween the distribution of a given protein and the pathogenicity
of the species where it is present. The 11 ARS-like protein families
that we have analyzed display very different distribution patterns
among bacterial phyla. A grosso modo, we can distinguish between
proteins that are universally or almost universally present, those
that are present in the majority of phyla, and those that are present
only in a minority of the main bacterial groups.
A wide distribution of a protein possibly reﬂects an ancient ori-
gin of the gene but lateral gene transfer, which is particularly wide-spread among bacteria, should always be considered an alternative
explanation. This is the case for the proteins CTP, EMAP II, YadB,
HisZ, and PoxA. Among this group are enzymes whose function is
completely unrelated to gene translation (CTP, HisZ, and PoxA)
and others that remain linked to tRNA biology (EMAP II and YadB).
Interestingly, PoxA is a well-known pathogenicity factor in Salmo-
nella [28]. However, its wide distribution suggests that its biologi-
cal function is not exclusively linked to the establishment of
infection, and the protein does not appear to be over-represented
in pathogenic species (Figs. 2 and 3). Obviously negative values
for enrichment in pathogens do not eliminate the possibility that
a protein is a virulence factor. However, signiﬁcant positive enrich-
ment rates should be indicative of proteins whose function is path-
ogenicity-related.
Abundant but not universally distributed bacterial ARS-like
families represent an important fraction of the set analyzed here
(AlaX, ATPS, BirA, YbaK). Interestingly, two trans editing domains
are present in this group, indicating that the need for misacylation
correction may not be universal among bacteria. The scattered dis-
tribution of these enzymes may suggest that lateral gene transfer
occurred among those species where the ﬁdelity of the genetic
code is particularly compromised and beneﬁts from the function
of in-trans editing domains [26].
It should be stressed that this situation needs not to be related
to the speciﬁc kinetic behavior of the concerned ARS but can be
caused by environmental conditions that, for instance, change
the relative availability of similar amino acids. This situation would
clearly favor the lateral transfer of these genes among species un-
der similar environmental stresses.
Finally a small set of proteins (AsnA and PrdX) present a very
limited distribution among bacteria. PrdX was originally described
as the trans-editing enzyme ProX from Clostridium sticklandii, and
shown to speciﬁcally deacylate alanyl-tRNAPro [13,36]. PrdX and
YbaK are two different trans-editing enzymes that hydrolyze dif-
ferent forms of mischarged tRNAPro [13]. Consistent with previous
reports, YbaK and PrdX groups do not overlap in our analysis. How-
466 E.M. Novoa et al. / FEBS Letters 584 (2010) 460–466ever, they do display overlapping distributions at the phylum level,
as would be expected from two independent editing domains that
recognize different substrates. Despite its more limited distribu-
tion PrdX is not over-represented in pathogenic bacteria (Fig. 3).
Asparagine synthetase (AsnA) is a paralog of asparagine- and
aspartyl-tRNA synthetases that displays a limited distribution
among bacterial phyla. AsnA is unique among the ARS-like proteins
analyzed here because it is signiﬁcantly over-represented in hu-
man pathogenic bacteria. AsnA has been shown to act as a viru-
lence factor in ﬁsh and plant pathogens, although the molecular
bases for this role in virulence remain unknown [7,8]. From our
data it is reasonable to predict that AsnA may also be a virulence
factor among human pathogens that, as such, deserves further
analysis and consideration as a potential therapeutic target.
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